Business Context and Reporting Period
Company: Camden National Corporation (CAC)
Filing Type: Form 8-K (Current Report)
Reporting Date: January 2, 2025 (Event Date: January 1, 2025)
Primary Event: Completion of the acquisition of Northway Financial, Inc. ("Northway") and its subsidiary, Northway Bank, pursuant to a Merger Agreement dated September 9, 2024. Northway merged into Camden National Corporation, and Northway Bank merged into Camden National Bank (CNB).
Key Financial Metrics and Transaction Details
- Total Consideration: Approximately $96.5 million in Camden National Corporation common stock.
- Exchange Ratio: 0.83 shares of Camden common stock for each share of Northway common stock (excluding Treasury Stock).
- Valuation Basis: Based on Camden's closing stock price of $42.25 on January 2, 2025.
- Fractional Shares: Cash paid in lieu of fractional shares.
- Existing Shareholders: Camden shares outstanding prior to the merger remained unchanged.
- Financial Statements: Required financial statements for the acquired business are not included in this filing; they will be filed by amendment within 71 days.
Material Changes and Governance Updates
Board of Directors Expansion: The Board size was increased by one seat. Larry K. Haynes, a former Northway director, was appointed effective upon merger completion.
- Committee Assignments: Mr. Haynes serves on the Audit Committee of the Camden Board and the Trust Committee of the CNB Board.
- Term: Serves until the 2025 Annual Meeting of Shareholders or until a successor is elected.
- Compensation:
- Annual cash retainer: $20,000.
- Meeting fees: $1,000 (Board), $825 (Audit Committee), $500 (Trust Committee).
- Equity award: Prorated 2024 independent director grant valued at $14,583.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the successful closing of the merger as previously announced. No specific forward-looking financial guidance or revenue projections were included in this specific 8-K text.
Risks and Contingencies: The filing notes that the description of the Merger Agreement is qualified by reference to the full agreement filed on September 10, 2024. No specific new risks were detailed in this report beyond standard merger integration implications.
Investor Verification Checklist
- Verify the final number of Camden shares issued to Northway shareholders based on the exact share count at closing.
- Review the full Merger Agreement (Exhibit 2.1 from the September 10, 2024 filing) for detailed terms and conditions.
- Monitor the upcoming amendment to this 8-K (due within 71 days) for the audited financial statements of Northway.
- Confirm the impact of the $96.5 million stock issuance on Camden's diluted earnings per share (EPS) in the next quarterly report.
- Check for any regulatory approvals or conditions related to the bank merger that may not yet be fully resolved.